GENRX LINEZOLID linezolid 600 mg tablet blister pack

Nazione: Australia

Lingua: inglese

Fonte: Department of Health (Therapeutic Goods Administration)

Principio attivo:

linezolid, Quantity: 600 mg

Commercializzato da:

Arrotex Pharmaceuticals Pty Ltd

INN (Nome Internazionale):

Linezolid

Forma farmaceutica:

Tablet, film coated

Composizione:

Excipient Ingredients: magnesium stearate; hypromellose; macrogol 8000; crospovidone; methylcellulose; titanium dioxide; hyprolose; silicon dioxide

Via di somministrazione:

Oral

Confezione:

10

Tipo di ricetta:

(S4) Prescription Only Medicine

Indicazioni terapeutiche:

Linezolid (intravenous or oral) is indicated for the treatment of suspected or proven infections due to Gram positive organisms resistant to multiple classes of antibiotics, including methicillin resistant Staphylococcus species and vancomycin resistant Enterococcus species. It is active against Gram-positive bacteria only and has no clinical activity against Gram-negative pathogens. Specific Gram-negative therapy is required if a concomitant Gram-negative pathogen is documented or suspected.

Dettagli prodotto:

Visual Identification: White coloured, oval shaped, biconvex, film-coated tablet with "APO" engraved on one side and "LIN600" on the other side.; Container Type: Blister Pack; Container Material: PVC/Al; Container Life Time: 24 Months; Container Temperature: Store below 30 degrees Celsius; Container Closure: Neither child resistant closure nor restricted flow insert

Stato dell'autorizzazione:

Licence status A

Data dell'autorizzazione:

2014-01-31